Abstract
Lymphatic filariasis (LF), frequently called elephantiasis, is a debilitating disease with serious social and economic impact. The infection is caused by worms of the species Wuchereria bancrofti, Brugia malayi, and B. timori. Parasites are transmitted by infected blood-feeding mosquitoes of different species of Culex, Aedes, Anopheles, and Mansonia. LF is endemic in 73 countries in Asia, Africa, and the Americas, with an estimated 120 million people affected, being 108 million of them infected with Wuchereria bancrofti and 12 million with Brugia malayi or B. timori. Filariasis is characterized by a broad spectrum of clinical disease, ranging from asymptomatic microfilaremic to acute and chronic lymphatic manifestations. In symptomatic patients the most common manifestations are hydrocele, lymphedema, and elephantiasis. The female worm produces microfilariae found in the bloodstream exhibiting a circadian rhythm (diurnal or nocturnal periodicity). Diagnosis can be performed by parasitological methods based on the detection of microfilariae by microscopic examination. Blood sample should be taken depending on parasite periodicity, when microfilariae concentration in the blood is higher. Serological techniques based on antigen detection or DNA amplification by polymerase chain reaction (PCR) can also be used. Diethylcarbamazine citrate (DEC) is considered the standard drug for filariasis therapy. However, chronic patients may not benefit from antifilarial drug requiring specific care to restore function of the affected area. Elimination programs strategies are mainly based on annual mass drug administration, environmental sanitation, vector control, treatment of infected individuals, and morbidity management to alleviate the physical disability and psychological suffering of chronically affected patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
<IndexTerm ID="ITerm83">Although several taxonomic modifications have been proposed on Culicidae genera, mostly splitting Aedes by Reinert et al. (2009) (and accepted by CBM), this taxonomy has been used in the chapters according to authors’ preference. To facilitate utilization by health personnel, all new aedine genera can be considered Aedes (CBM).
- 2.
Methanol is very toxic for humans and primates by ingestion, skin contact, or breathing. In rhesus monkeys, minimal lethal dose by oral route, which causes symptoms similar to those in humans (irreversible blindness, acidosis, and death), is 3 g/kg.
References
Bockarie MJ (2007) Molecular xenomonitoring of lymphatic filariasis. Am J Trop Med Hyg 77:591–592
Dreyer G, Norões J, Figueiredo-Silva J et al (2000) Pathogenesis of lymphatic disease in Bancroftian filariasis: a clinical perspective. Parasitol Today 16:544–548
Fischer P, Supali T, Maizels RM (2004) Lymphatic filariasis and Brugia timori: prospects for elimination. Trends Parasitol 20:351–355
Fontes G, Rocha EMM (2011) Wuchereria bancrofti—Filariose linfática. In: Neves DP, Melo AL, Linardi PM et al (eds) Parasitologia humana, 12th edn. Atheneu, Rio de Janeiro, pp 323–333
Fontes G, Rocha EMM, Brito AC et al (2000) The microfilarial periodicity of Wuchereria bancrofti in northeastern Brazil. Ann Trop Med Parasitol 94:373–379
Harinasuta C, Sucharit S, Deesin T et al (1970) Studies on the nocturnally subperiodic strain of Wuchereria bancrofti from West Thailand. Southeast Asian J Trop Med Public Health 1:152–158
Hawking F, Jennings T, Louis FJ et al (1981) The mechanisms which affect the periodic cycle of Pacific Wuchereria bancrofti microfilariae. J Helminthol 55:95–100
Ichimori K, King JD, Engels D et al (2014) Global programme to eliminate lymphatic filariasis: the processes underlying programme success. PLoS Negl Trop Dis 8, e3328
Lammie P, Milner T, Houston R (2007) Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis. Bull World Health Organ 85:545–549
Paily KP, Hoti SL, Das PK (2009) A review of the complexity of biology of lymphatic filarial parasites. J Parasit Dis 33:3–12
Pfarr KM, Debrah AY, Specht S et al (2009) Filariasis and lymphoedema. Parasite Immunol 31:664–672
Rahmah N, Shenoy RK, Nutman TB et al (2003) Multicentre laboratory evaluation of Brugia rapid dipstick test for detection of brugian filariasis. Trop Med Int Health 8:895–900
Ramaiah KD, Ottesen EA (2014) Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease. PLoS Negl Trop Dis 8, e3319
Rocha EMM, Fontes G, Brito AC et al (2000) Bancroftian filariasis in urban areas of Alagoas State, Northeast Brazil: study in general population. Rev Soc Bras Med Trop 33:545–551
Shenoy RK (2008) Clinical and pathological aspects of filarial lymphedema and its management. Korean J Parasitol 46:119–125
Vasuki V, Hoti SL, Sadanandane C et al (2003) A simple and rapid DNA extraction method for the detection of Wuchereria bancrofti infection in the vector mosquito Culex quinquefasciatus by SspI PCR assay. Acta Trop 86:109–114
Weil GJ, Ramzy RM (2007) Diagnostic tools for filariasis elimination programs. Trends Parasitol 23:78–82
Weil GJ, Curtis KC, Fischer PU et al (2011) A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14. Acta Trop 120(Suppl 1):S19–S22
WHO – World Health Organization (1992) Lymphatic filariasis: the disease and its control. Fifth report of the WHO Expert Committee on Filariasis, Geneva Technical reports series, 821, 75 pp
WHO – World Health Organization (2008) Global programme to eliminate lymphatic filariasis. Progress report on mass drug administrations in 2007. Wkly Epidemiol Rec 83:333–348
WHO – World Health Organization (2010) Progress report 2000–2009 and strategic plan 2010–2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis, Geneva. Available: http://whqlibdoc.who.int/publications/2010/9789241500722_eng.pdf
WHO – World Health Organization (2011) Global programme to eliminate lymphatic filariasis: progress report on mass drug administration in 2010. Wkly Epidemiol Rec 86(35):377–388
WHO – World Health Organization (2013) Lymphatic filariasis: a handbook of practical entomology for national lymphatic filariasis elimination programmes, Geneva, WHO/HTM/NTD/PCT/2013.10. Available: http://apps.who.int/iris/bitstream/10665/87989/1/9789241505642_eng.pdf
WHO – World Health Organization (2014) Lymphatic filariasis. Fact sheet No. 102. Available: http://www.who.int/mediacentre/factsheets/fs102/en/ Accessed 10 Jan 2015
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
da Rocha, E.M.M., Fontes, G., Ehrenberg, J.P. (2017). Lymphatic Filariasis. In: Marcondes, C. (eds) Arthropod Borne Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-13884-8_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-13884-8_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13883-1
Online ISBN: 978-3-319-13884-8
eBook Packages: MedicineMedicine (R0)